시장보고서
상품코드
1839102

간 질환 치료 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 디바이스별, 최종 사용자별, 치료 단계별(-2034년)

Liver Disease Treatment Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, Device, End User, Treatment Stage

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 440 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

간 질환 치료 시장은 2024년 266억 달러에서 2034년에는 448억 달러로 확대될 전망이며, CAGR 약 5.4%로 성장할 것으로 예측됩니다. 간 질환 치료 시장에는 간염, 간경변, 간암 등 간 질환의 관리 및 치유를 목적으로 하는 치료제나 의약품이 포함됩니다. 이 시장을 견인하고 있는 것은 간질환의 유병률 증가, 치료법의 진보, 헬스케어 지출 증가입니다. 주요 동향은 표적 생물학적 제형, 비침습적 진단 도구 및 개인화된 의료 접근법의 개발을 포함합니다. 시장 성장은 조기 진단 및 간 질환의 효과적인 관리를 강조하는 계발 캠페인과 정부 이니셔티브에 의해 더욱 촉진됩니다.

간 질환 치료 시장은 치료 접근법의 진보와 질병 이환율 증가에 의해 진화하고 있습니다. 약물 치료 분야는 간질환 관리에 있어서의 효능으로부터 항바이러스제와 면역억제제를 필두로 업적을 견인하고 있습니다. 생물학적 제형과 표적 치료제는 환자의 예후를 개선하는 개인화된 치료 옵션을 제공하며, 두 번째로 업적이 높은 부문으로 기세를 늘리고 있습니다. 외과적 치료, 특히 간 이식은 여전히 중요하지만, 저침습 치료가 바람직한 옵션으로 부상하고 있습니다. 이미징 기술 및 바이오마커 검사와 같은 진단의 진보는 조기 발견과 개입을 지원하고 치료의 성공률을 높이고 있습니다. 비침습적 진단 기술은 환자 친화적인 접근법으로의 변화를 반영하여 증가하는 경향이 있습니다. 원격 의료 및 원격 모니터링을 포함한 디지털 건강 솔루션의 통합도 확대되어 지속적인 환자 참여 및 관리가 가능합니다. 이러한 동향은 간질환 치료에서 투자와 기술 혁신의 큰 기회를 부각시키고 있습니다.

시장 세분화
유형별 간염, 비알코올성 지방성 간질환(NAFLD), 알코올성 간질환, 간암, 간경변
제품별 의약품, 생물제제, 백신, 영양보조식품
서비스별 진단, 치료 서비스, 간 이식
기술별 유전자 치료, 줄기 세포 치료, CRISPR, 단백질체학, 바이오 마커 탐색
용도별 임상 용도, 연구 용도
디바이스별 간 기능 검사 기기, 영상 진단 기기, 생검 기기
최종 사용자별 병원, 클리닉, 연구 기관, 진단 실험실
치료 단계별 초기 스테이지, 중간 스테이지, 진행 스테이지

시장 현황

시장 상황 : 간 질환 치료 시장은 시장 점유율 분포, 가격 전략, 제품 혁신 등 역동적인 전개를 특징으로 합니다. 이 분야에서는 바이오테크놀러지와 제약 연구의 진보에 견인되어 신제품 출시가 급증하고 있습니다. 각 회사는 혁신적인 치료 솔루션을 제공함으로써 시장 점유율을 얻으려고 전략적 포지셔닝을 하고 있습니다. 가격 경쟁은 여전히 계속되고 있으며 제조 비용, 규제 당국의 승인, 시장 수요 등의 요인에 영향을 받고 있습니다. 북미와 유럽은 시장 점유율로 선도하고 있으며, 아시아태평양은 의료 투자 증가로 중요한 성장 지역으로 부상하고 있습니다. 간 질환 치료 시장의 경쟁은 치열하고, 주요 기업은 경쟁력을 높이기 위해 연구 개발에 주력하고 있습니다. 경쟁업체에 대한 벤치마킹에는 제품 효능, 안전성 프로파일 및 비용 효율성 분석이 포함됩니다. 규제 당국의 영향은 매우 중요한 역할을 하고 있으며, 엄격한 지침이 제품 승인 및 시장 진입에 영향을 미치고 있습니다. 시장은 FDA와 EMA와 같은 기관의 정책에 의해 형성되며 안전성과 혁신성 기준을 규정하고 있습니다. 또한 전략적 제휴, 합병 및 인수가 시장 확대 및 침투를 촉진하고 있습니다.

주요 동향 및 성장 촉진요인 :

간 질환 치료 시장은 세계적인 간 질환 유병률의 상승에 힘입어 강력한 성장을 이루고 있습니다. 주요 동향은 신규 치료제의 개발과 치료 프로토콜에 대한 첨단 기술의 도입 등이 있습니다. 바이오의약품 기업은 미충족 요구에 대응하는 혁신적인 솔루션을 시장에 투입하기 위해 연구 개발에 많은 투자를 하고 있습니다. 비알코올성 지방 간 질환(NAFLD)과 간염의 이환율 증가는 인구의 노화와 함께 효과적인 치료에 대한 수요를 촉진하고 있습니다. 정부 및 의료기관은 조기 진단과 조기 개입을 중시하고 있으며 시장 확대를 더욱 뒷받침하고 있습니다. 또한 정밀의료 및 개인화 치료의 출현은 환자 치료에 혁명을 가져오고 치료 성적을 향상시키는 맞춤형 치료 옵션을 제공합니다. 의료 인프라가 개선되고 진보된 치료에 대한 접근이 확대되고 있는 신흥 시장에는 치료 기회가 풍부합니다. 비용 효율적이고 확장 가능한 솔루션을 제공할 수 있는 기업은 이러한 기회를 활용하는 데 유리한 입장에 있습니다. 또한 제약기업과 연구기관의 협업이 혁신을 촉진하고 차세대 치료법 개발을 가속화하고 있습니다. 간 질환 치료 시장은 기술의 진보와 환자의 QOL 향상에 주력함으로써 지속적인 성장이 예상됩니다.

성장 억제요인 및 과제 :

간 질환 치료 시장은 몇 가지 심각한 억제요인 및 과제에 직면하고 있습니다. 주요 과제는 혁신적인 치료법의 비용이 높다는 점이며, 저소득 지역의 환자 접근이 제한되어 있습니다. 많은 헬스케어 시스템이 치료비 비축에 고민하고 있으며, 치료 접근과 치료 성적 불평등으로 이어지고 있습니다. 또한 규제상의 장애물과 긴 승인 과정이 새로운 치료법의 도입을 늦추고 기술 혁신과 시장 확대를 저해하고 있습니다. 다양한 병인과 증상을 가진 간 질환의 복잡성은 진단과 치료를 복잡하게 하며 전문 지식과 장비가 필요합니다. 이 복잡성은 오진과 치료 지연을 초래하여 환자 결과에 영향을 미칩니다. 게다가 간 질환을 훈련받은 숙련된 헬스케어 전문가가 부족하여 증가하는 환자 집단을 효과적으로 관리하는 능력에 한계가 있습니다. 마지막으로 간 질환, 특히 라이프스타일 선택과 관련된 간 질환과 관련된 스티그마(낙인)는 환자가 적시에 의료 개입을 요구하는 것을 망설이게 하고, 헬스케어 시스템의 부담을 더욱 악화시켜 시장 성장을 방해할 수 있습니다.

주요 기업

Intercept Pharmaceuticals, Madrigal Pharmaceuticals, Dicerna Pharmaceuticals, Galectin Therapeutics, Conatus Pharmaceuticals, Akero Therapeutics, Gilead Sciences, Ascletis Pharma, Genfit, CymaBay Therapeutics, Arbutus Biopharma, Hepion Pharmaceuticals, Enyo Pharma, Alnylam Pharmaceuticals, Mirum Pharmaceuticals, Albireo Pharma, Spring Bank Pharmaceuticals, Viking Therapeutics, Zydus Cadila, BioVie

목차

제1장 간 질환 치료 시장 개요

  • 조사 목적
  • 간 질환 치료 시장 정의 및 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 간 질환 치료 시장 전망

  • 간 질환 치료 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 간 질환 치료 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 간 질환 치료 시장 규모

  • 간 질환 치료 시장 규모 : 금액별
  • 간 질환 치료 시장 규모 : 수량별

제7장 간 질환 치료 시장 : 유형별

  • 시장 개요
  • 간염
  • 비알코올성 지방성 간질환(NAFLD)
  • 알코올성 간질환
  • 간암
  • 간경변
  • 기타

제8장 간 질환 치료 시장 : 제품별

  • 시장 개요
  • 의약품
  • 생물제제
  • 백신
  • 영양보조식품
  • 기타

제9장 간 질환 치료 시장 : 서비스별

  • 시장 개요
  • 진단 서비스
  • 치료 서비스
  • 간 이식
  • 기타

제10장 간 질환 치료 시장 : 기술별

  • 시장 개요
  • 유전자 치료
  • 줄기세포 치료
  • CRISPR
  • 단백질체학
  • 바이오마커 탐색
  • 기타

제11장 간 질환 치료 시장 : 용도별

  • 시장 개요
  • 임상 용도
  • 연구 용도
  • 기타

제12장 간 질환 치료 시장 : 디바이스별

  • 시장 개요
  • 간기능 검사 기기
  • 화상 진단 기기
  • 생검 기기
  • 기타

제13장 간 질환 치료 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 연구기관
  • 진단 실험실
  • 기타

제14장 간 질환 치료 시장 : 치료 단계별

  • 시장 개요
  • 초기 단계
  • 중간 단계
  • 진행 단계
  • 기타

제15장 간 질환 치료 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제16장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제17장 기업 프로파일

  • Medpace
  • ICON Clinical Research
  • PRA Health Sciences
  • Parexel International
  • IQVIA
  • Charles River Laboratories
  • Syneos Health
  • Covance
  • PPD
  • WuXi AppTec
  • KCR
  • Clinipace
  • Medelis
  • Novotech
  • Advanced Clinical
  • BioClinica
  • Pharm-Olam
  • Worldwide Clinical Trials
  • Tigermed
  • Frontage Laboratories
AJY 25.11.14

Liver Disease Treatment Market is anticipated to expand from $26.6 billion in 2024 to $44.8 billion by 2034, growing at a CAGR of approximately 5.4%. The Liver Disease Treatment Market encompasses therapies and medications aimed at managing and curing liver conditions, including hepatitis, cirrhosis, and liver cancer. This market is driven by increasing liver disease prevalence, advancements in treatment modalities, and rising healthcare expenditure. Key trends include the development of targeted biologics, non-invasive diagnostic tools, and personalized medicine approaches. The market's growth is further fueled by awareness campaigns and government initiatives, emphasizing early diagnosis and effective management of liver diseases.

The Liver Disease Treatment Market is evolving, driven by advancements in therapeutic approaches and increasing disease prevalence. The drug therapy segment leads in performance, with antiviral drugs and immunosuppressants at the forefront due to their efficacy in managing liver conditions. Biologics and targeted therapies are gaining momentum as the second-highest performing segment, offering personalized treatment options that improve patient outcomes. The surgical treatment segment, particularly liver transplantation, remains critical, yet minimally invasive procedures are emerging as a preferred alternative. Diagnostic advancements, such as imaging technologies and biomarker testing, support early detection and intervention, enhancing treatment success rates. Non-invasive diagnostic techniques are on the rise, reflecting a shift towards patient-friendly approaches. The integration of digital health solutions, including telemedicine and remote monitoring, is also expanding, enabling continuous patient engagement and management. These trends highlight significant opportunities for investment and innovation within the liver disease treatment landscape.

Market Segmentation
TypeHepatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease, Liver Cancer, Cirrhosis
ProductPharmaceuticals, Biologics, Vaccines, Nutraceuticals
ServicesDiagnostics, Therapeutic Services, Liver Transplantation
TechnologyGene Therapy, Stem Cell Therapy, CRISPR, Proteomics, Biomarker Discovery
ApplicationClinical Applications, Research Applications
DeviceLiver Function Test Devices, Imaging Devices, Biopsy Devices
End UserHospitals, Clinics, Research Institutes, Diagnostic Laboratories
Treatment StageEarly Stage, Intermediate Stage, Advanced Stage

Market Snapshot:

The Liver Disease Treatment Market is characterized by a dynamic landscape of market share distribution, pricing strategies, and product innovations. This sector is witnessing a surge in new product launches, driven by advancements in biotechnology and pharmaceutical research. Companies are strategically positioning themselves to capture market share by offering innovative treatment solutions. Pricing remains competitive, influenced by factors such as production costs, regulatory approvals, and market demand. North America and Europe lead in terms of market share, with Asia-Pacific emerging as a significant growth region due to increasing healthcare investments. Competition in the Liver Disease Treatment Market is intense, with key players focusing on research and development to gain a competitive edge. Benchmarking against competitors involves analyzing product efficacy, safety profiles, and cost-effectiveness. Regulatory influences play a crucial role, with stringent guidelines impacting product approvals and market entry. The market is shaped by policies from agencies such as the FDA and EMA, which dictate standards for safety and innovation. The landscape is further defined by strategic alliances, mergers, and acquisitions, facilitating expansion and market penetration.

Geographical Overview:

The liver disease treatment market is witnessing substantial growth across various regions, each presenting unique opportunities. North America dominates the landscape, driven by advanced healthcare infrastructure and a high prevalence of liver diseases. The region's robust research and development initiatives further bolster market expansion. Europe follows, with significant attention to innovative treatment modalities and government support for liver disease management. Asia Pacific is rapidly emerging as a key growth pocket, propelled by increasing healthcare investments and rising awareness about liver health. China and India are at the forefront, with expanding healthcare sectors and a growing patient population. In Latin America, Brazil shows promising potential as healthcare advancements and economic development fuel market growth. The Middle East & Africa region is gradually gaining momentum, with countries like the UAE investing in healthcare infrastructure and liver disease treatment. These emerging markets present lucrative opportunities for stakeholders aiming to expand their footprint in the liver disease treatment arena.

Key Trends and Drivers:

The Liver Disease Treatment Market is experiencing robust growth, propelled by the rising prevalence of liver diseases worldwide. Key trends include the development of novel therapeutics and the integration of advanced technologies in treatment protocols. Biopharmaceutical companies are investing heavily in research and development to bring innovative solutions to market, addressing unmet medical needs. The increasing incidence of non-alcoholic fatty liver disease (NAFLD) and hepatitis, coupled with the aging population, is driving demand for effective treatments. Governments and healthcare organizations are emphasizing early diagnosis and intervention, further boosting market expansion. Moreover, the advent of precision medicine and personalized therapies is revolutionizing patient care, providing tailored treatment options that improve outcomes. Opportunities abound in emerging markets where healthcare infrastructure is improving, and access to advanced treatments is expanding. Companies that can deliver cost-effective and scalable solutions are well-positioned to capitalize on these opportunities. Additionally, collaborations between pharmaceutical firms and research institutions are fostering innovation and accelerating the development of next-generation therapies. The Liver Disease Treatment Market is poised for sustained growth, driven by technological advancements and a focus on enhancing patient quality of life.

Restraints and Challenges:

The liver disease treatment market is confronted with several significant restraints and challenges. A primary challenge is the high cost of innovative therapies, which restricts access for patients in lower-income regions. Many healthcare systems struggle to afford these treatments, leading to unequal access and outcomes. Additionally, regulatory hurdles and lengthy approval processes delay the introduction of new therapies, stifling innovation and market expansion. The complexity of liver disease, with its various etiologies and manifestations, complicates diagnosis and treatment, requiring specialized knowledge and equipment. This complexity can result in misdiagnosis or delayed treatment, impacting patient outcomes. Furthermore, there is a shortage of skilled healthcare professionals trained in hepatology, which limits the capacity to manage the growing patient population effectively. Lastly, the stigma associated with liver diseases, particularly those linked to lifestyle choices, can deter patients from seeking timely medical intervention, further exacerbating the burden on healthcare systems and hindering market growth.

Key Players:

Intercept Pharmaceuticals, Madrigal Pharmaceuticals, Dicerna Pharmaceuticals, Galectin Therapeutics, Conatus Pharmaceuticals, Akero Therapeutics, Gilead Sciences, Ascletis Pharma, Genfit, CymaBay Therapeutics, Arbutus Biopharma, Hepion Pharmaceuticals, Enyo Pharma, Alnylam Pharmaceuticals, Mirum Pharmaceuticals, Albireo Pharma, Spring Bank Pharmaceuticals, Viking Therapeutics, Zydus Cadila, BioVie

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Liver Disease Treatment Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Liver Disease Treatment Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by Device
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Treatment Stage
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by Device
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Treatment Stage
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Liver Disease Treatment Market Outlook

  • 4.1 Liver Disease Treatment Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Liver Disease Treatment Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Liver Disease Treatment Market Size

  • 6.1 Liver Disease Treatment Market Size, by Value
  • 6.2 Liver Disease Treatment Market Size, by Volume

7: Liver Disease Treatment Market, by Type

  • 7.1 Market Overview
  • 7.2 Hepatitis
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Non-Alcoholic Fatty Liver Disease (NAFLD)
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Alcoholic Liver Disease
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Liver Cancer
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Cirrhosis
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: Liver Disease Treatment Market, by Product

  • 8.1 Market Overview
  • 8.2 Pharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Biologics
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Vaccines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Nutraceuticals
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Liver Disease Treatment Market, by Services

  • 9.1 Market Overview
  • 9.2 Diagnostics
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Therapeutic Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Liver Transplantation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Liver Disease Treatment Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Therapy
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Stem Cell Therapy
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 CRISPR
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Proteomics
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Biomarker Discovery
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Liver Disease Treatment Market, by Application

  • 11.1 Market Overview
  • 11.2 Clinical Applications
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Research Applications
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Liver Disease Treatment Market, by Device

  • 12.1 Market Overview
  • 12.2 Liver Function Test Devices
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Imaging Devices
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Biopsy Devices
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Liver Disease Treatment Market, by End User

  • 13.1 Market Overview
  • 13.2 Hospitals
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Clinics
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Diagnostic Laboratories
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Liver Disease Treatment Market, by Treatment Stage

  • 14.1 Market Overview
  • 14.2 Early Stage
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Intermediate Stage
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Advanced Stage
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Liver Disease Treatment Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Services
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by Application
    • 15.2.7 North America Market Size and Forecast, by Device
    • 15.2.8 North America Market Size and Forecast, by End User
    • 15.2.9 North America Market Size and Forecast, by Treatment Stage
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Services
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by Application
      • 15.2.9.6 United States Market Size and Forecast, by Device
      • 15.2.9.7 United States Market Size and Forecast, by End User
      • 15.2.9.8 United States Market Size and Forecast, by Treatment Stage
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Services
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by Application
      • 15.2.10.6 Canada Market Size and Forecast, by Device
      • 15.2.10.7 Canada Market Size and Forecast, by End User
      • 15.2.10.8 Canada Market Size and Forecast, by Treatment Stage
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Services
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by Application
    • 15.3.7 Europe Market Size and Forecast, by Device
    • 15.3.8 Europe Market Size and Forecast, by End User
    • 15.3.9 Europe Market Size and Forecast, by Treatment Stage
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.6 United Kingdom Market Size and Forecast, by Device
      • 15.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Treatment Stage
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Services
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by Application
      • 15.3.10.6 Germany Market Size and Forecast, by Device
      • 15.3.10.7 Germany Market Size and Forecast, by End User
      • 15.3.10.8 Germany Market Size and Forecast, by Treatment Stage
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Services
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by Application
      • 15.3.11.6 France Market Size and Forecast, by Device
      • 15.3.11.7 France Market Size and Forecast, by End User
      • 15.3.11.8 France Market Size and Forecast, by Treatment Stage
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Services
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by Application
      • 15.3.12.6 Spain Market Size and Forecast, by Device
      • 15.3.12.7 Spain Market Size and Forecast, by End User
      • 15.3.12.8 Spain Market Size and Forecast, by Treatment Stage
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Services
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by Application
      • 15.3.13.6 Italy Market Size and Forecast, by Device
      • 15.3.13.7 Italy Market Size and Forecast, by End User
      • 15.3.13.8 Italy Market Size and Forecast, by Treatment Stage
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Services
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by Application
      • 15.3.14.6 Netherlands Market Size and Forecast, by Device
      • 15.3.14.7 Netherlands Market Size and Forecast, by End User
      • 15.3.14.8 Netherlands Market Size and Forecast, by Treatment Stage
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Services
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by Application
      • 15.3.15.6 Sweden Market Size and Forecast, by Device
      • 15.3.15.7 Sweden Market Size and Forecast, by End User
      • 15.3.15.8 Sweden Market Size and Forecast, by Treatment Stage
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Services
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by Application
      • 15.3.16.6 Switzerland Market Size and Forecast, by Device
      • 15.3.16.7 Switzerland Market Size and Forecast, by End User
      • 15.3.16.8 Switzerland Market Size and Forecast, by Treatment Stage
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Services
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by Application
      • 15.3.17.6 Denmark Market Size and Forecast, by Device
      • 15.3.17.7 Denmark Market Size and Forecast, by End User
      • 15.3.17.8 Denmark Market Size and Forecast, by Treatment Stage
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Services
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by Application
      • 15.3.18.6 Finland Market Size and Forecast, by Device
      • 15.3.18.7 Finland Market Size and Forecast, by End User
      • 15.3.18.8 Finland Market Size and Forecast, by Treatment Stage
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Services
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by Application
      • 15.3.19.6 Russia Market Size and Forecast, by Device
      • 15.3.19.7 Russia Market Size and Forecast, by End User
      • 15.3.19.8 Russia Market Size and Forecast, by Treatment Stage
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by Device
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Treatment Stage
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.7 Asia-Pacific Market Size and Forecast, by Device
    • 15.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Treatment Stage
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Services
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by Application
      • 15.4.9.6 China Market Size and Forecast, by Device
      • 15.4.9.7 China Market Size and Forecast, by End User
      • 15.4.9.8 China Market Size and Forecast, by Treatment Stage
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Services
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by Application
      • 15.4.10.6 India Market Size and Forecast, by Device
      • 15.4.10.7 India Market Size and Forecast, by End User
      • 15.4.10.8 India Market Size and Forecast, by Treatment Stage
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Services
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by Application
      • 15.4.11.6 Japan Market Size and Forecast, by Device
      • 15.4.11.7 Japan Market Size and Forecast, by End User
      • 15.4.11.8 Japan Market Size and Forecast, by Treatment Stage
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Services
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by Application
      • 15.4.12.6 South Korea Market Size and Forecast, by Device
      • 15.4.12.7 South Korea Market Size and Forecast, by End User
      • 15.4.12.8 South Korea Market Size and Forecast, by Treatment Stage
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Services
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by Application
      • 15.4.13.6 Australia Market Size and Forecast, by Device
      • 15.4.13.7 Australia Market Size and Forecast, by End User
      • 15.4.13.8 Australia Market Size and Forecast, by Treatment Stage
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Services
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by Application
      • 15.4.14.6 Singapore Market Size and Forecast, by Device
      • 15.4.14.7 Singapore Market Size and Forecast, by End User
      • 15.4.14.8 Singapore Market Size and Forecast, by Treatment Stage
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Services
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by Application
      • 15.4.15.6 Indonesia Market Size and Forecast, by Device
      • 15.4.15.7 Indonesia Market Size and Forecast, by End User
      • 15.4.15.8 Indonesia Market Size and Forecast, by Treatment Stage
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Services
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by Application
      • 15.4.16.6 Taiwan Market Size and Forecast, by Device
      • 15.4.16.7 Taiwan Market Size and Forecast, by End User
      • 15.4.16.8 Taiwan Market Size and Forecast, by Treatment Stage
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Services
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by Application
      • 15.4.17.6 Malaysia Market Size and Forecast, by Device
      • 15.4.17.7 Malaysia Market Size and Forecast, by End User
      • 15.4.17.8 Malaysia Market Size and Forecast, by Treatment Stage
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Treatment Stage
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Services
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by Application
    • 15.5.7 Latin America Market Size and Forecast, by Device
    • 15.5.8 Latin America Market Size and Forecast, by End User
    • 15.5.9 Latin America Market Size and Forecast, by Treatment Stage
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Services
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by Application
      • 15.5.9.6 Brazil Market Size and Forecast, by Device
      • 15.5.9.7 Brazil Market Size and Forecast, by End User
      • 15.5.9.8 Brazil Market Size and Forecast, by Treatment Stage
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Services
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by Application
      • 15.5.10.6 Mexico Market Size and Forecast, by Device
      • 15.5.10.7 Mexico Market Size and Forecast, by End User
      • 15.5.10.8 Mexico Market Size and Forecast, by Treatment Stage
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Services
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by Application
      • 15.5.11.6 Argentina Market Size and Forecast, by Device
      • 15.5.11.7 Argentina Market Size and Forecast, by End User
      • 15.5.11.8 Argentina Market Size and Forecast, by Treatment Stage
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by Device
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Treatment Stage
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.7 Middle East and Africa Market Size and Forecast, by Device
    • 15.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Treatment Stage
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by Device
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Treatment Stage
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Services
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by Application
      • 15.6.10.6 UAE Market Size and Forecast, by Device
      • 15.6.10.7 UAE Market Size and Forecast, by End User
      • 15.6.10.8 UAE Market Size and Forecast, by Treatment Stage
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Services
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by Application
      • 15.6.11.6 South Africa Market Size and Forecast, by Device
      • 15.6.11.7 South Africa Market Size and Forecast, by End User
      • 15.6.11.8 South Africa Market Size and Forecast, by Treatment Stage
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by Device
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Treatment Stage
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Medpace
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 ICON Clinical Research
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 PRA Health Sciences
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Parexel International
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 IQVIA
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Charles River Laboratories
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Syneos Health
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Covance
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 PPD
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 WuXi AppTec
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 KCR
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 Clinipace
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Medelis
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Novotech
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Advanced Clinical
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 BioClinica
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Pharm-Olam
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Worldwide Clinical Trials
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 Tigermed
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Frontage Laboratories
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제